Patents by Inventor Sunil Chauhan

Sunil Chauhan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240123032
    Abstract: This application discloses ophthalmic formulations and methods for treating and preventing corneal haze and scarring with an hepatocyte growth factor (HGF) agent.
    Type: Application
    Filed: June 1, 2023
    Publication date: April 18, 2024
    Inventors: Sunil Chauhan, Reza Dana
  • Patent number: 11759499
    Abstract: This application discloses ophthalmic formulations and methods for treating and preventing corneal haze and scarring with an hepatocyte growth factor (HGF) agent.
    Type: Grant
    Filed: April 20, 2021
    Date of Patent: September 19, 2023
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Sunil Chauhan, Reza Dana
  • Patent number: 11306140
    Abstract: Methods and compositions for reducing the activity or number of memory Th17 cells in ocular tissue, and for treatment and/or prevention of ocular immunoinflammatory diseases are described.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: April 19, 2022
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Reza Dana, Sunil Chauhan, Yihe Chen
  • Publication number: 20220088119
    Abstract: Described herein are materials and methods of treating dry eye disease in a subject.
    Type: Application
    Filed: April 9, 2021
    Publication date: March 24, 2022
    Inventors: Reza Dana, Sunil Chauhan
  • Patent number: 11241497
    Abstract: The invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-17 and methods for using this composition to treat IL-17-mediated ocular inflammatory disorders. The invention also discloses devices for delivering this composition to the eye.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: February 8, 2022
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Reza Dana, Sunil Chauhan
  • Publication number: 20210299219
    Abstract: This application discloses ophthalmic formulations and methods for treating and preventing corneal haze and scarring with an hepatocyte growth factor (HGF) agent.
    Type: Application
    Filed: April 20, 2021
    Publication date: September 30, 2021
    Inventors: Sunil Chauhan, Reza Dana
  • Publication number: 20210154263
    Abstract: Described herein are materials and methods for treating dry eye disease in a subject.
    Type: Application
    Filed: January 19, 2021
    Publication date: May 27, 2021
    Inventors: Reza Dana, Sunil Chauhan
  • Patent number: 10940179
    Abstract: Described herein are materials and methods for treating dry eye disease in a subject.
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: March 9, 2021
    Assignee: SCHEPENS EYE RESEARCH INSTITUTE
    Inventors: Reza Dana, Sunil Chauhan
  • Patent number: 10799874
    Abstract: The present disclosure relates to a pulverizer includes a pulverizer housing with an grinding assembly having a grinding table situated therein. The grinding table provides a grinding surface area for a material, such as a fossil fuel, such as coal, to be pulverized. The grinding table is mounted on a gearbox shaft operatively connected to a gearbox drive mechanism so as to be capable of driven rotation within the pulverizer housing. A journal assembly having a journal head and the journal assembly and a spring assembly are mounted on the pulverizer housing so that the journal head engage the spring assembly.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: October 13, 2020
    Assignee: GENERAL ELECTRIC TECHNOLOGY GMBH
    Inventors: Satya Sai Ramchandra Rao Indraganti, Krishnendu Aditya, Sunil Chauhan, Mahesh Govind Kendhe
  • Publication number: 20200121758
    Abstract: This application discloses ophthalmic formulations and methods for treating and preventing corneal haze and scarring with an hepatocyte growth factor (HGF) agent.
    Type: Application
    Filed: October 18, 2019
    Publication date: April 23, 2020
    Inventors: Sunil Chauhan, Reza Dana
  • Patent number: 10449234
    Abstract: This application discloses ophthalmic formulations and methods for treating and preventing corneal haze and scarring with an hepatocyte growth factor (HGF) agent.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: October 22, 2019
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Sunil Chauhan, Reza Dana
  • Publication number: 20190151404
    Abstract: Described herein are materials and methods of treating dry eye disease in a subject.
    Type: Application
    Filed: November 29, 2018
    Publication date: May 23, 2019
    Inventors: Reza Dana, Sunil Chauhan
  • Publication number: 20190046603
    Abstract: Described herein are materials and methods for treating dry eye disease in a subject.
    Type: Application
    Filed: May 23, 2018
    Publication date: February 14, 2019
    Inventors: Reza Dana, Sunil Chauhan
  • Patent number: 10179160
    Abstract: Described herein are materials and methods of treating dry eye disease in a subject.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: January 15, 2019
    Assignee: SCHEPENS EYE RESEARCH INSTITUTE
    Inventors: Reza Dana, Sunil Chauhan
  • Publication number: 20190008765
    Abstract: Methods and compositions for reducing the activity or number of memory Th17 cells in ocular tissue, and for treatment and/or prevention of ocular immunoinflammatory diseases are described.
    Type: Application
    Filed: January 6, 2017
    Publication date: January 10, 2019
    Inventors: Reza Dana, Sunil Chauhan, Yihe Chen
  • Patent number: 10117906
    Abstract: The invention provides methods and compositions for minimizing, preventing, or treating damage to corneal nerves by administering to a subject with such damage or at risk of exposure to such damage a composition which blocks an activity of an IL-1 cytokine and/or an IL-17 cytokine.
    Type: Grant
    Filed: January 11, 2010
    Date of Patent: November 6, 2018
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Reza Dana, Mohammad Dastjerdi, Sunil Chauhan
  • Publication number: 20180256685
    Abstract: This application discloses ophthalmic formulations and methods for treating and preventing corneal haze and scarring with an hepatocyte growth factor (HGF) agent.
    Type: Application
    Filed: September 9, 2016
    Publication date: September 13, 2018
    Inventors: Sunil Chauhan, Reza Dana
  • Publication number: 20180092976
    Abstract: The invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-17 and methods for using this composition to treat IL-17-mediated ocular inflammatory disorders. The invention also discloses devices for delivering this composition to the eye.
    Type: Application
    Filed: December 14, 2017
    Publication date: April 5, 2018
    Inventors: Reza Dana, Sunil Chauhan
  • Patent number: 9872901
    Abstract: The invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-17 and methods for using this composition to treat IL-17-mediated ocular inflammatory disorders. The invention also discloses devices for delivering this composition to the eye.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: January 23, 2018
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Reza Dana, Sunil Chauhan
  • Publication number: 20160361412
    Abstract: The invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-17 and methods for using this composition to treat IL-17-mediated ocular inflammatory disorders. The invention also discloses devices for delivering this composition to the eye.
    Type: Application
    Filed: March 7, 2016
    Publication date: December 15, 2016
    Inventors: Reza Dana, Sunil Chauhan